Dataset Information


Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression.

ABSTRACT: Introduction of cDNA or genomic clones of the tumor suppressor in lung cancer 1 (TSLC1) gene into the non-small cell lung cancer line, A549, reverses tumorigenic growth properties of these cells. These results and the observation that TSLC1 is down-regulated in a number of tumors suggest that TSLC1 functions as a critical switch mediating repression of tumorigenesis.To investigate this mechanism, we compared growth properties of A549 with the TSLC1-containing derivative. We found a G1/S phase transition delay in 12.2. Subtractive hybridization, quantitative PCR, and TranSignal Protein/DNA arrays were used to identify genes whose expression changed when TSLC1 was up-regulated. Members of common G1/S phase regulatory pathways such as TP53, MYC, RB1 and HRAS were not differentially expressed, indicating that TSLC1 may function through an alternative pathway(s). A number of genes involved in cell proliferation and tumorigenesis were differentially expressed, notably genes in the Ras-induced senescence pathway. We examined expression of several of these key genes in human tumors and normal lung tissue, and found similar changes in expression, validating the physiological relevance of the A549 and 12.2 cell lines.Gene expression and cell cycle differences provide insights into potential downstream pathways of TSLC1 that mediate the suppression of tumor properties in A549 cells.


PROVIDER: S-EPMC1208945 | BioStudies | 2005-01-01

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3258782 | BioStudies
2006-01-01 | S-EPMC1447413 | BioStudies
2008-06-12 | E-GEOD-3676 | BioStudies
2011-01-01 | S-EPMC3039374 | BioStudies
2006-01-01 | S-EPMC1447408 | BioStudies
2008-06-12 | E-GEOD-3676 | ArrayExpress
1000-01-01 | S-EPMC4420595 | BioStudies
2018-01-01 | S-EPMC6316077 | BioStudies
2020-01-01 | S-EPMC7470448 | BioStudies
2019-01-01 | S-EPMC6359307 | BioStudies